About Spansules
Spansules is a Healthcare company based in Hyderabad (India) founded in 2000. Pharmaceutical pellet manufacturing and formulation development in India. The company has 52 employees. Its Indian entity Spansules Pharmatech Private Limited reported revenue of ₹73.76 Cr. Spansules offers products and services including Orlistat Pellets and Tamsulosin Pellets. Its focus areas include Pharmaceuticals, Formulation Development, Contract Manufacturing and Generic Drug Pellets.
Company details
Spansules is identified as a pharmaceutical company that was established in 2000, with manufacturing and RD facilities dedicated to pellet production. It is recognized for adhering to WHO-GMP and ISO 9001:2015 standards, where products like Orlistat and Tamsulosin pellets are developed for sustained and delayed release. Contract-based customization and formulation services are provided, contributing to advancements in generic drugs. The companys operations are based in Hyderabad, India, focusing on quality and innovation in healthcare solutions. (72 words)
- Headquarters Hyderabad, India
- Employees 52
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn Facebook
- Legal Name Spansules Pharmatech Private Limited
- Date of Incorporation 09 Oct, 2000
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹73.76 Cr
FY 2025 · -4% YoY
- Net Profit₹1.73 Cr
FY 2025 · 2% margin
- EBITDA₹8.06 Cr
FY 2025 · 11% margin
- Employee Count52
Associated legal entities of Spansules
Spansules operates through Spansules Pharmatech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Spansules Pharmatech Private Limited CIN U24230TG2000PTC035421 | Active | 09 Oct 2000 | Hyderabad, Telangana | ₹73.8 Cr | 52 | 4 | View details |
Products & Services of Spansules
Spansules offers a comprehensive portfolio of products and services, including Orlistat Pellets and Tamsulosin Pellets.
Orlistat pellets are produced for anti-obesity applications, with formulations that are customized for sustained release
Tamsulosin pellets are developed for anti-BPH treatments, focusing on sustained release to enhance drug efficacy
Board of directors of Spansules Pharmatech Private Limited (Spansules)
Spansules Pharmatech Private Limited is the primary company behind Spansules. The board of Spansules Pharmatech Private Limited currently have 4 directors; the longest-serving is Rama Devi Guttikonda, appointed in 2000.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rama Devi Guttikonda DIN 02019526 | Director | 09 Oct 2000 | 26 yrs | Spansules Pharmatech Private Limited |
| Venkata Subba Rao Guttikonda DIN 01900749 | Managing Director | 09 Oct 2000 | 26 yrs | Spansules Pharmatech Private Limited |
| Haswanth Rao Guttikonda DIN 06368794 | Director | 07 Feb 2020 | 6 yrs 8 mo | Spansules Pharmatech Private Limited |
| Harika Rao Guttikonda DIN 07585257 | Director | 07 Feb 2020 | 6 yrs 8 mo | Spansules Pharmatech Private Limited |
People of Spansules
1 people are tracked at Spansules (1 in leadership); the tracked headcount is 52.
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership |
Complete people profiles for Spansules
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Spansules
Figures of Spansules Pharmatech Private Limited, the primary company behind Spansules, for FY 2025. Revenue was ₹73.76 Cr (-4% year on year). Net profit was ₹1.73 Cr (2% margin). EBITDA was ₹8.06 Cr (11% margin). Revenue has grown at a compounded annual rate of -2% over three years and +5% over five years.
- ₹73.76 CrRevenue · FY 2025 · -4% YoY
- ₹1.73 CrNet profit · 2% margin
- ₹8.06 CrEBITDA · 11% margin
- ₹5.00 CrPaid-up capital
- 52Employees (provident fund records)
- -2%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Spansules Pharmatech Private Limited are on its company page.
Detailed financial statements for Spansules
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Spansules
The website of Spansules (spansulespharma.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▼ 0.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Spansules
Spansules was founded in 2000.
Spansules is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Spansules has 52 employees.
The primary company behind Spansules, Spansules Pharmatech Private Limited, reported revenue of ₹73.76 Cr for FY 2025, down 4% year on year.
Spansules is identified as a pharmaceutical company that was established in 2000, with manufacturing and RD facilities dedicated to pellet production. It is recognized for adhering to WHO-GMP and ISO 9001:2015 standards, where products like Orlistat and Tamsulosin pellets are developed for sustained and delayed release. Contract-based customization and formulation services are provided, contributing to advancements in generic drugs. The companys operations are based in Hyderabad, India, focusing on quality and innovation in healthcare solutions. (72 words).
Spansules offers Orlistat Pellets and Tamsulosin Pellets.
Spansules operates through Spansules Pharmatech Private Limited.
The legal entities of Spansules currently have 4 directors, including Rama Devi Guttikonda, Haswanth Rao Guttikonda, Harika Rao Guttikonda and others.